Accessibility Menu
 
Precigen logo

Precigen

(NASDAQ) PGEN

Current Price$3.29
Market Cap$1.30B
Since IPO (2013)-85%
5 Year-51%
1 Year+124%
1 Month-4%

Precigen Financials at a Glance

Market Cap

$1.30B

Revenue (TTM)

$9.68M

Net Income (TTM)

$250.64M

EPS (TTM)

$-1.40

P/E Ratio

-2.62

Dividend

$0.00

Beta (Volatility)

1.75 (High)

Price

$3.29

Volume

4,956,401.575

Open

$3.61

Previous Close

$3.67

Daily Range

$3.29 - $3.67

52-Week Range

$1.11 - $5.46

PGEN: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Precigen

Industry

Biotechnology

Employees

160

CEO

Helen Sabzevari, PhD

Headquarters

Germantown, MD 20876, US

PGEN Financials

Key Financial Metrics (TTM)

Gross Margin

42%

Operating Margin

-11%

Net Income Margin

-26%

Return on Equity

-572%

Return on Capital

-93%

Return on Assets

-2%

Earnings Yield

-38.17%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$1.30B

Shares Outstanding

353.93M

Volume

4.96M

Short Interest

0.00%

Avg. Volume

4.44M

Financials (TTM)

Gross Profit

$3.59M

Operating Income

$106.60M

EBITDA

$103.40M

Operating Cash Flow

$87.83M

Capital Expenditure

$2.00M

Free Cash Flow

$89.83M

Cash & ST Invst.

$97.86M

Total Debt

$5.12M

Precigen Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2025YOY CHG

Revenue

$4.57M

+283.6%

Gross Profit

$2.65M

+12523.8%

Gross Margin

58.07%

N/A

Market Cap

$1.30B

N/A

Market Cap/Employee

$9.08M

N/A

Employees

143

N/A

Net Income

$23.50M

-19.1%

EBITDA

$20.53M

-7.2%

Quarterly Fundamentals

Name
Q4 2025YOY CHG

Net Cash

$92.74M

+0.4%

Accounts Receivable

$4.36M

+275.1%

Inventory

$9.58M

N/A

Long Term Debt

$3.98M

-12.5%

Short Term Debt

$1.14M

+18.8%

Return on Assets

-1.60%

N/A

Return on Invested Capital

-92.62%

N/A

Free Cash Flow

$24.08M

-159.8%

Operating Cash Flow

$23.46M

-184.6%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
NKTRNektar Therapeutics
$65.25-4.97%
IMTXImmatics N.V.
$9.32-0.53%
TRMLTourmaline Bio, Inc.
$47.98+0.00%
ORICORIC Pharmaceuticals, Inc.
$12.01-0.44%

Trending Stocks

Symbol / CompanyPricePrice Chg
NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF
$8.38+0.01%
TQQQProShares Trust - ProShares UltraPro Qqq
$38.52-0.01%
SQQQProShares Trust - ProShares UltraPro Short Qqq
$88.01+0.01%
FRMIFermi
$5.41-0.13%

Questions About PGEN

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.